Difference between revisions of "Resource:19344715-932f-4599-b6db-cef280258d52"
From The Embassy of Good Science
| Line 11: | Line 11: | ||
|Has Link=https://journals.sagepub.com/doi/10.1111/jlme.12072 | |Has Link=https://journals.sagepub.com/doi/10.1111/jlme.12072 | ||
}} | }} | ||
| − | {{Related To}} | + | {{Related To |
| + | |Related To Theme=Theme:92439f75-5c0c-49d4-a21f-e9b41bd3a7db | ||
| + | }} | ||
{{Tags | {{Tags | ||
|Has Virtue And Value=Honesty | |Has Virtue And Value=Honesty | ||
Revision as of 13:39, 20 May 2020
ResourcesCases
The ethics of pharmaceutical research funding: A social organization approach
What is this about?
This is a fictional case which advances a social organization approach to examining unethical behavior. To illustrate the value of a social organization approach, a case study of a medical school professor's first experience with pharmaceutical-company-sponsored research is provided in order to examine how funding arrangements can constrain research integrity[1].
Why is this important?
While unethical behaviors may stem in part from failures in individual morality or psychological blind spots, they are both generated and performed through social interactions among individuals and groups[1]
- ↑ Gray, Garry C. "The ethics of pharmaceutical research funding: A social organization approach." (2013): 629-634.
